Carbonaceous
materials
have
gained
significant
attention
in
recent
years
for
their
various
applications
the
field
of
medicine
and
biotechnology.
This
comprehensive
review
explores
synthesis
characterization
carbon-based
potentials
medical
applications.
The
paper
delves
into
methods
fabrication
nanoparticles,
such
as
carbon
nanotubes,
biochar,
graphene,
while
highlighting
unique
properties.
Characterization
techniques,
microscopy,
spectroscopy,
surface
analysis,
are
discussed
to
provide
insights
chemical
structural
properties
these
materials.
Furthermore,
examined
wide-ranging
applications,
encompassing
tissue
engineering,
drug
delivery,
biosensing,
imaging,
showcasing
versatility
promising
contributions
carbonaceous
healthcare
industry.
outlines
current
challenges
prospects
field,
emphasizing
growing
significance
valuable
tools
advancing
science
technology,
well
public
health.
Alzheimer's
disease
(AD)
is
characterized
by
progressive
cognitive
decline
and
neuronal
loss,
commonly
linked
to
amyloid-β
plaques,
neurofibrillary
tangles,
neuroinflammation.
Recent
research
highlights
the
gut
microbiota
as
a
key
player
in
modulating
neuroinflammation,
critical
pathological
feature
of
AD.
Understanding
role
this
process
essential
for
uncovering
new
therapeutic
avenues
gaining
deeper
insights
into
AD
pathogenesis.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(20), P. 3570 - 3570
Published: Oct. 21, 2024
Recent
research
highlights
the
growing
interest
in
impact
of
nutrition
on
cognitive
health
and
function
disease,
as
dietary
habits
are
increasingly
recognized
crucial
factors
relation
to
brain
function.
This
focus
is
especially
important
given
rising
prevalence
neurodegenerative
diseases
decline
associated
with
poor
choices.
Links
now
being
sought
between
microbiota
gut-brain
axis.
Mechanisms
proposed
that
include
low-grade
chronic
neuroinflammation,
influence
short-chain
fatty
acids,
or
disruption
glial
cells
transmitters
brain.
Ethnopharmacological
relevance:
Pterocarpus
mildbraedii
was
believed
to
have
multiple
benefits,
including
antioxidant,
antipyretic,
antalgic,
anti-convulsant,
and
anxiolytic
effects.
Previous
studies
reported
that
water
extract
(Pm)
contained
secondary
metabolites
able
cross
the
BBB.
However,
Pm's
systemic
mechanism
targets
for
neuroinflammation
remain
largely
unexplored.Aim
of
study:
This
research
used
a
systems
pharmacology
approach
experiment
evaluation
reveal
potential
protective
effects
Pm
against
neuroinflammation,
oxidative
stress,
behavioral
changes
in
an
LPS-induced
Alzheimer's
disease
(AD)
rat
model.Materials
methods:
integrated
network
analysis
experimental
verification
evaluate
pharmacological
PM
AD
systematically.
Swiss
Target
Prediction,
GeneCards,
STRING
databases
were
employed
identify
targets.
The
interaction
between
active
components
hub
confirmed
via
molecular
docking.
GO
KEGG
pathway
analyses
also
carried
out.
Further,
vitro
bioassays
explore
anti-inflammatory
antioxidant
activities
and,
finally,
vivo
neuroinflammatory
stress
markers.Results:
Network
docking
revealed
primarily
regulates
signaling
pathways
such
as
ESR1,
ESR2,
BACE1,
MAPK1,
TLR4,
IL6,
GSK3B
through
like
liquiritigenin
pterocarptriol.
identified
significant
action
AD,
nitrogen
metabolism
VEGF
pathway.
In
vitro,
demonstrated
their
properties,
along
with
inhibitory
on
AchE
BchE.
Behavioral
tests
showed
LPS
exposure
impaired
exploratory
behavior,
spatial
learning,
increased
anxiety
rats,
correlating
brain,
marked
by
elevated
MDA
NO
levels,
decreased
CAT,
SOD,
GSH
levels.
raised
TNF-α
IL-6
levels
while
reducing
dopamine,
serotonin,
AChE
activity.
Notably,
treatment
significantly
mitigated
improved
activity,
restored
neurotransmitter
animals.Conclusion:
paper
established
P.
could
inhibit
its
components,
targets,
pathways.
milbraedii
may
be
candidate
treatment.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(3), P. 687 - 687
Published: Feb. 4, 2025
Changes
in
population
demographics
indicate
that
the
elderly
will
reach
2.1
billion
worldwide
by
2050.
In
parallel,
there
be
an
increase
neurodegenerative
diseases
such
as
Alzheimer’s
and
Parkinson’s.
This
review
explores
dysbiosis
occurring
these
pathologies
how
virulence
factors
contribute
to
worsening
or
development
of
clinical
conditions,
it
summarizes
existing
potential
ways
combat
microorganisms
related
diseases.
Microbiota
imbalances
can
progression
increasing
intestinal
permeability,
exchanging
information
through
innervation,
even
acting
a
Trojan
horse
affecting
immune
cells.
The
microbiota
produce
protect
themselves
from
host
defenses,
many
which
These
are
expressed
according
genetic
composition
each
microorganism,
leading
wide
range
considered.
Among
main
LPS,
urease,
curli
proteins,
amyloidogenic
VacA,
CagA.
also
packed
into
bacterial
outer
membrane
vesicles,
transport
RNA,
DNA,
enabling
distal
communication
impacts
various
diseases,
including
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: Feb. 18, 2025
During
severe
acute
pancreatitis
(SAP),
damage
to
the
intestinal
mucosal
barrier
and
translocation
of
pathogenic
bacteria
are
key
mechanisms
that
accelerate
disease
progression
SAP.
Chaihuang
Qingyi
Huoxue
Granule
(CH)
is
a
herbal
formula
used
in
clinical
treatment
This
study
aims
investigate
role
CH
regulating
gut
microbiota
SAP
rats.
Sodium
taurocholate
(3.5%)
was
retrogradely
perfused
into
biliopancreatic
duct
establish
model
(4.4
g/kg)
administered
by
gavage.
Serum
amylase,
lipase,
endotoxin
levels
were
measured.
Hematoxylin-eosin
(HE)
staining
observe
morphological
changes
pancreas
colon.
The
expression
zona
occludens-1
(ZO-1)
occludin
colon
examined
immunohistochemistry
(IHC)
western
blot.
16S
rDNA
gene
sequencing
analyze
content
short-chain
fatty
acids
(SCFAs)
contents
rats
determined
gas
chromatography-mass
spectrometry
(GC-MS).
reduced
serum
rats,
alleviated
pathological
colon,
restored
ZO-1
occludin.
Moreover,
dysbiosis
with
diversity
structure.
At
phylum
level,
relative
abundance
Firmicutes
Bacteroidetes
increased,
while
Proteobacteria
decreased.
genus
Ruminococcus
1,
Parabacteroides,
Prevotellaceae
UCG-001,
Lachnospiraceae
NK4A136
group,
Lactobacillus
Escherichia-Shigella,
Enterococcus,
Enterobacter
In
addition,
increased
SCFAs
ameliorates
maintaining
homeostasis
microbiota,
increasing
SCFAs,
repairing
barrier.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
Abstract
Background
and
purpose:
Alzheimer's
disease
(AD)
is
a
neurodegenerative
characterized
by
progressive
cognitive
dysfunction,
which
common
in
the
elderly.
In
recent
years,
it
has
been
reported
that
glucagon-like
peptide
1
(GLP-1)
analogues
have
neuroprotective
function.
However,
mechanism
of
GLP-1
improving
neurological
function
not
fully
clarified.
This
study
attempts
to
clarify
alleviating
AD
phenotype.
Methods:
this
study,
modified
once-weekly
analogue,
Semaglutide,
was
used
treat
8-month-old
amyloid
precursor
protein
/
presenilin
(APP/PS1)
transgenic
mice.
By
means
ethology,
molecular
biology
16s
rRNA
amplicon
sequencing,
confirmed
Semaglutide
alleviated
phenotype
APP/PS1
Results:
improved
behavioral
performance
mice,
reduced
neuronal
damage
aggregation
amyloid-β
(Aβ)
plaques,
enhanced
synaptic
plasticity.
also
attenuated
pyroptosis
mediated
NOD-like
receptor
thermal
domain
associated
3
(NLRP3),
inflammatory
reaction
toll-like
4
(TLR4)
mitochondrial
microglia
as
well
structure
blood-brain
barrier
(BBB)
Conclusion:
may
repair
alleviate
central
nervous
system
injury
caused
displacement
pyrogen
gut
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 11, 2025
ABSTRACT
Disturbances
in
the
gut
microbiome
is
increasing
correlated
with
neurodegenerative
disorders,
including
Alzheimer’s
Disease.
The
may
fact
influence
disease
pathology
AD
by
triggering
or
potentiating
systemic
and
neuroinflammation,
thereby
driving
along
“microbiota-gut-brain-axis”.
Currently,
drivers
of
cognitive
decline
symptomatic
progression
remain
unknown
understudied.
Changes
composition
offer
clues
to
potential
physiologic
neuropathologic
changes
that
contribute
decline.
Here,
we
recruited
a
cohort
260
older
adults
(age
60+)
living
community
followed
them
over
time,
tracking
objective
measures
cognition,
clinical
information,
microbiomes.
Subjects
were
classified
as
healthy
controls
having
mild
impairment
based
on
performance.
Those
diagnosis
Diseases
confirmed
using
serum
biomarkers.
Using
metagenomic
sequencing,
found
relative
species
abundances
well
cognition
status
(MCI
AD).
Furthermore,
gene
pathways
analyses
suggest
certain
microbial
metabolic
either
be
maintaining
function.
Specifically,
genes
involved
urea
cycle
production
methionine
cysteine
predicted
worse
Our
study
suggests
predict